25I-NBMD
25I-NBMD[edit]
25I-NBMD is a synthetic psychedelic compound that belongs to the NBOMe class of drugs. It is a derivative of the phenethylamine 2C-I and is known for its potent hallucinogenic effects. The compound is primarily used in research settings and has been studied for its interactions with the 5-HT2A receptor.
Chemical Structure[edit]
25I-NBMD is chemically related to other NBOMe compounds, such as 25I-NBOMe and 25C-NBOMe. The structure of 25I-NBMD includes a methoxybenzyl group attached to the nitrogen atom of the 2C-I backbone, which significantly increases its affinity for the 5-HT2A receptor. This modification is responsible for its increased potency compared to its parent compound, 2C-I.
Pharmacology[edit]
25I-NBMD acts as a potent agonist at the 5-HT2A receptor, which is the primary target for many psychedelic substances. Activation of this receptor is associated with the psychedelic effects experienced by users, including altered perception, mood, and cognition. The compound's high affinity for the 5-HT2A receptor makes it a valuable tool in neuroscience research for studying the role of this receptor in the brain.
Effects[edit]
The effects of 25I-NBMD are similar to those of other psychedelics, such as LSD and psilocybin. Users report visual and auditory hallucinations, changes in thought patterns, and an altered sense of time. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Safety and Legal Status[edit]
Due to its potent effects and potential for misuse, 25I-NBMD is classified as a controlled substance in many countries. Its use is primarily restricted to scientific research, and it is not approved for medical use. The safety profile of 25I-NBMD is not well-established, and there have been reports of adverse effects, including vasoconstriction, tachycardia, and hypertension.
